Gilead — Drug Prices & Medicare Spending

Gilead manufactures 15 drugs tracked by Medicare Part D with total spending of $14.7B.

Drugs Tracked

$14.7B

Medicare Spending

$2,735.34

Avg Cost/Claim

87%

Have Generics

Gilead Drugs — Ranked by Medicare Spending

#	Drug	Generic Name	Cost/Claim	Medicare Spending	YoY Change	Generic?
1	Biktarvy	Bictegravir/Emtricitabine/TAF	$3,746.00	$3.8B	+12.8%	No
2	Genvoya	Elvitegravir/Cobicistat/Emtricitabine/TAF	$3,619.00	$2.3B	-8.4%	Yes
3	Descovy	Emtricitabine/TAF	$2,418.00	$1.6B	+12.4%	Yes
4	Harvoni	Ledipasvir/Sofosbuvir	$24,958.00	$1.2B	-38.2%	No
5	Epclusa	Sofosbuvir/Velpatasvir	$26,143.00	$1.1B	-15.7%	Yes
6	Trodelvy	Sacituzumab Govitecan	$15,643.00	$876.0M	+68.4%	Yes
7	Truvada	Emtricitabine/Tenofovir DF	$2,066.00	$876.0M	-32.4%	Yes
8	Odefsey	Emtricitabine/Rilpivirine/TAF	$3,532.00	$876.0M	-8.4%	Yes
9	Letairis	Ambrisentan	$8,338.00	$567.0M	-4.8%	Yes
10	Complera	Emtricitabine/Rilpivirine/TDF	$4,012.00	$345.0M	-24.6%	Yes
11	Vemlidy	Tenofovir Alafenamide	$1,855.00	$345.0M	+8.4%	Yes
12	Sovaldi	Sofosbuvir	$13,000.00	$234.0M	-42.4%	Yes
13	Sunlenca	Lenacapavir	$9,750.00	$234.0M	0.0%	Yes
14	Vosevi	Sofosbuvir/Velpatasvir/Voxilaprevir	$14,833.00	$178.0M	-28.6%	Yes
15	Ranolazine	Ranolazine	$96.00	$178.0M	-8.6%	Yes

Gilead manufactures 15 drugs tracked by Medicare Part D, with total annual spending of $14.7B.

Epclusa (Sofosbuvir/Velpatasvir) is the most expensive at $26,143.00 per claim.

13 of 15 Gilead drugs (87%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.